Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Accounts Payables (2020 - 2025)

BioAtla (BCAB) has disclosed Accounts Payables for 6 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • For Q4 2025, Accounts Payables rose 330.81% year-over-year to $8.2 million; the TTM value through Dec 2025 reached $8.2 million, up 330.81%, while the annual FY2025 figure was $8.2 million, 330.81% up from the prior year.
  • Accounts Payables hit $8.2 million in Q4 2025 for BioAtla, up from $5.9 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $34.0 million in Q3 2023 and bottomed at $1.2 million in Q1 2022.
  • Average Accounts Payables over 5 years is $12.1 million, with a median of $8.1 million recorded in 2023.
  • Year-over-year, Accounts Payables skyrocketed 1340.45% in 2022 and then crashed 95.77% in 2024.
  • BioAtla's Accounts Payables stood at $18.4 million in 2021, then rose by 17.29% to $21.6 million in 2022, then plummeted by 82.33% to $3.8 million in 2023, then crashed by 50.2% to $1.9 million in 2024, then skyrocketed by 330.81% to $8.2 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $8.2 million, $5.9 million, and $4.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.